WAT Waters Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 56
Relative Strength: Rel. Strength: 64
Relative Valuation: Rel. Valuation: 26
Relative Profitability: Rel. Profitability: 90

EPS in 2025 (TTM): $10.91

Last Report Period Date: Sep 27, 2025

Based on the company's latest reports for September 2025, the current 12-month EPS is $10.91. Waters's earnings per share in 2024 was reported at $10.75, marking a decline from $10.87 in 2023. In the quarterly report ending on Sep 27, 2025, WAT's earnings per share amounted to $2.5.

WAT earnings history

Historical annual and quarterly earnings per share (EPS) data for Waters
EPS (TTM)
$10.91
EPS Growth YoY (Quarterly)
-8.1%
EPS (Quarterly)
$2.5
EPS Growth (Quarterly)
1.2%

Waters had an yealy earnings per share of $10.75, showing a decline of 1.1% from $10.87 recorded in 2023. The quarterly earnings per share for the period ending Sep 27, 2025, was $2.5, showing a 8.1% decline compared to the same quarter last year. The trailing twelve months EPS for WAT is $10.91 as of September 2025. Waters's full-year EPS for 2023 was $10.87, a 7.9% decline compared to the previous year.

WAT EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-8.1%
EPS growth YoY
-1.1%
EPS growth 3Y avg
-1.5%
EPS growth 5Y avg
4.2%

Waters has recorded a decline in earnings per share of 8.1% in the past 12 months (YoY, quarterly). During the past three years, WAT registered an average yearly EPS growth of -1.5%. Waters had an average annual EPS growth of 4.2% in the last five years. Over the last decade, WAT had an average annual earnings per share growth of 7.7%.

WAT Earnings Waterfall

Breakdown of revenue, profit and net income for Waters

WAT Earnings vs Peers

What are the earnings of WAT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
TMO Thermo Fisher Scientific Inc 32.74 6.8% -5.5% 12.4%
WAT Waters Corp 34.09 -1.1% -1.5% 4.2%
A Agilent Technologies Inc 34.29 5.2% 3.7% 5.4%
MTD Mettler Toledo International Inc 36.37 12.7% 6.9% 12.2%
GE General Electric Co 40.36 -28.4% N/A N/A
DHR Danaher Corp 43.49 -17.2% -15.3% 5.3%
BRKR Bruker Corp 77.31 -74% -25.4% -9.8%
BIO Bio-Rad Laboratories Inc N/A -199.5% N/A N/A
HBIO Harvard Bioscience Inc N/A -250% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.